←
Dr. Laura Jonkman3,131 posts
Dr. Laura Jonkman avatar

Dr. Laura Jonkman

@NeuroLaura

Neuroscientist (Ass. Prof) studying the pathological sensitivity of MR images in neurodegenerative disease (AD/PD). Also loves teaching, and penguins.

◷ Joined July 2010▧ 299 Photos and videos
Milan Němý avatar
⟳ Dr. Laura Jonkman retweeted
Milan Němý@milan_nemy·Mar 13

PhD position 🎓 at CIIRC CTU, Prague: computational modeling of structural brain connectivity from diffusion MRI. Work on tractography, ML, and computational neuroscience with applications in cognition, aging, and neurological disease. Deadline: March 31. beat.ciirc.cvut.cz/doctoral-…

Post attachment
Dr. Laura Jonkman avatar
Dr. Laura Jonkman@NeuroLaura·19 Nov 2025

Nice to see our work online 🤩

Brain@Brain187817 Nov 2025

Using post-mortem MRI and immunohistochemistry, Wesseling et al. show that brain donors with LATE-NC have lower amygdalar and hippocampal volumes than non-LATE-NC donors, even when correcting for regional p-tau, amyloid-beta, and alpha-synuclein burden. tinyurl.com/43sbp5fr

Post attachment
Neuroimaging PIA avatar
⟳ Dr. Laura Jonkman retweeted
Neuroimaging PIA@NeuroimagingPIA·3 Nov 2025

There is still time to register for our upcoming webinar. Everything on postmortem imaging, this Thursday (Nov 6)! Sign up here: act.alz.org/site/R?i=X6Sk2e4…

Interested in postmortem imaging? Join us at the next webinar, where latest advances of postmortem imaging in ADRD will be discussed! Speakers: @NeuroLaura & Pulkit Khandelwal Panel: @DadarMahsa & @paul_yushkevich 📅 Thursday, November 6 🕗 9am CT 👉 alz-org.zoom.us/webinar/regi…

Post attachment
Erik Middlebrooks, MD avatar
⟳ Dr. Laura Jonkman retweeted
Erik Middlebrooks, MD@EMiddlebrooksMD·25 Aug 2025

Agreed! Can’t count how many times I have seen alternative diagnoses first suggested by MRI findings or even refinement of “Parkinson’s” diagnosis, such as an atypical syndrome or even rarer things like PLA2G6 mutation. While volumetric tools often lag behind relative to presentation, we have more advanced tools now that allow us to directly measure the earliest stages of the disease like iron deposition in SN, depletion of neuromelanin, etc. As radiologists and ordering physicians, we have to move beyond the idea that we just check for strokes and tumors in patients with neurodegenerative disorders—we have the tools now to provide much more info. Diagnosis is multidisciplinary but imaging can be a powerful biomarker when obtained and interpreted correctly!

Should every person with suspected Parkinson’s get an MRI? For decades, neurologists have relied on history and examination as the gold standard for diagnosing Parkinson’s disease. Routine MRI scans have not been recommended for people with a classic presentation. However, more and more cases have been emerging and Maas, Bloem and colleagues have challenged us to 'rethink' a potentially outdated approach. Key Points: - The authors remind us that a careful history and neurological examination remain essential for diagnosing Parkinson’s disease. - MRI can occasionally uncover a treatable mimic. - The authors shared two cases that looked like classical Parkinson’s, however MRI revealed other causes: one person had a brain tumor, another had familial brain calcifications. - The absence of clear non-motor symptoms may be more concerning than the author’s originally thought and they therefore argue that we should LOWER THE THRESHOLD for brain imaging. My take: Maybe we should order a MRI for every person w/ Parkinson’s and/or a suspected neurodegenerative disease? David Vaillancourt and his multi-center PSG/NIH study has also recently shown that a 6 minute MRI sequence can be useful to separate PD from PSP and from MSA. Here are 5 points that resonated w/ me about this particular study. 1- Expert evaluation remains the backbone of a Parkinson’s diagnosis. 2- An MRI is not always ordered, but sometimes it can reveal a different and treatable condition. 3- If there are no typical non-motor symptoms like loss of smell, constipation, or dream enactment, doctors may actually need to be more cautious. 4- Getting one MRI early in the process may prevent delays in the right diagnosis and treatment. 5- Ongoing research is shaping how we use imaging to better care for people with suspected Parkinson’s disease. Does your Parkinson's plan pdplan.org account for other diagnoses? pn.bmj.com/content/early/202… @Fixelinstitute @parkinsondotorg #parkinson @SfNtweets @movedisorder @TheASNR @EMiddlebrooksMD @DBSThinkTank @basbloem

Post attachment
My Neuropath News avatar
⟳ Dr. Laura Jonkman retweeted
My Neuropath News@NeuropathClinic·20 Aug 2025

18F-FDG PET in detection of primary age-related tauopathy (PART) – Is there a role? Insights from an imaging-pathology correlation study alz-journals.onlinelibrary.w…

Dr. Laura Jonkman avatar
Dr. Laura Jonkman@NeuroLaura·30 Jun 2025

🚨 Another new manuscript from the team! On an imaging marker for LATE-NC as co-pathology in neurodegeneration.

Brain@Brain187829 Jun 2025

Using post-mortem in situ MRI, Wesseling et al. show that brain donors with LATE-NC have lower amygdalar and hippocampal volumes than non-LATE-NC donors, even when correcting for regional phosphorylated tau, amyloid-b, and a-syn. tinyurl.com/34p435bd

Post attachment
Dr. Laura Jonkman avatar
Dr. Laura Jonkman@NeuroLaura·10 May 2025

🚨 New manuscript from the team! @NeuroNiels’ first first-author paper, a wonderful collaboration with Qynapse! pubmed.ncbi.nlm.nih.gov/4028…

Emma Coomans avatar
⟳ Dr. Laura Jonkman retweeted
Emma Coomans@EmmaCoomans·28 Apr 2025

So excited and honored to be invited to present the opening plenary at #AIC2025 this year in Toronto! 🧠 🙏 I would be very grateful if you could help me gather the most inspiring papers (including your own!) of the past year by completing this survey: alz.surveymonkey.com/r/923BT…

🚨Calling all neuroimagers! Help @EmmaCoomans shape the opening plenary at #AIC2025 (Toronto, July 26th) "Accomplishments of the Past Year" and share the most impactful neuroimaging research from the past year via this brief survey (~5min) by May 30th. act.alz.org/site/R?i=eOejFv9…

Michael Schöll avatar
⟳ Dr. Laura Jonkman retweeted
Michael Schöll@_michael_scholl·17 Jan 2025

Always my favourite post at the beginning of the year: Registration for our course “Biomarkers for neurodegenerative diseases” is now open! This year’s edition takes place at @UCLIoN in central London on May 12-16. biomarker-course.org

Maria Popova avatar
⟳ Dr. Laura Jonkman retweeted
Maria Popova@themarginalian·22 Dec 2024

We live in a state of perpetual dissociation from the almost unbearable wonder of being alive. But if we fell asleep each night remembering “the singularity we once were” and awoke each morning with the bright awareness that every atom in our bodies can be traced to one of the first stars... we would be too wonder-struck by the miraculousness of it all to deal with the mundane. The dishes have to be washed and the emails have to be written, so we avert our eyes from the majesty and mystery of a universe that made them in order to look at itself, from the majesty and mystery of what we are. themarginalian.org/2024/12/0…